Figure 7.
Tumor growth inhibition and downregulation of intratumoral R2 expression in Kasumi-1 xenograft tumor-bearing mice. Tumor-bearing mice (n = 4) were treated with various formulations of GTI-2040 (3 mg/kg), as described in Materials and Methods. (A) Inhibition of tumor growth. (B) Intratumoral R2 mRNA expression.